Total Payments
$2,507
2024 Payments
$30.46
Companies
20
Transactions
156
Medicare Patients
963
Medicare Billing
$57,350
Payment Breakdown by Category
Food & Beverage$2,507 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,507 | 156 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $612.81 | 50 | $0 (2024) |
| Novo Nordisk Inc | $505.04 | 31 | $0 (2022) |
| ABBVIE INC. | $484.14 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $210.47 | 6 | $0 (2022) |
| Gilead Sciences, Inc. | $162.26 | 14 | $0 (2022) |
| Radius Health, Inc. | $114.78 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $68.30 | 4 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $62.44 | 3 | $0 (2021) |
| Ethicon Inc. | $60.51 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $36.49 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.46 | 2 | GlaxoSmithKline, LLC. ($16.09) |
| 2023 | $28.78 | 2 | Janssen Pharmaceuticals, Inc ($15.50) |
| 2022 | $652.31 | 38 | Novo Nordisk Inc ($241.37) |
| 2021 | $1,796 | 114 | AbbVie Inc. ($394.81) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Neuroscience | ||||||
| 02/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.34 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Diabetes | ||||||
| 07/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $83.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.85 | General |
| 06/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: RESPIRATORY | ||||||
| 06/02/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 05/24/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diabetes | ||||||
| 05/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.19 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 21 | $4,410 | $1,351 |
| 2022 | 3 | 191 | 212 | $41,995 | $11,807 |
| 2021 | 5 | 328 | 431 | $90,922 | $23,121 |
| 2020 | 9 | 424 | 498 | $93,010 | $21,071 |
Total Patients
963
Total Services
1,162
Medicare Billing
$57,350
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 21 | $4,410 | $1,351 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 56 | 56 | $10,080 | $5,805 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 91 | $19,110 | $4,061 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 65 | $12,805 | $1,941 | 15.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 187 | $39,270 | $10,715 | 27.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 171 | $33,687 | $5,995 | 17.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 30 | 30 | $5,400 | $3,119 | 57.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $9,120 | $2,309 | 25.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $3,445 | $983.50 | 28.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 163 | 194 | $40,740 | $7,656 | 18.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 153 | $30,141 | $4,684 | 15.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $4,140 | $2,094 | 50.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Facility | 2020 | 31 | 31 | $3,844 | $1,800 | 46.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2020 | 12 | 12 | $2,844 | $1,646 | 57.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 12 | 12 | $2,160 | $1,109 | 51.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $5,472 | $928.56 | 17.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $2,600 | $692.82 | 26.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Facility | 2020 | 31 | 31 | $697.50 | $245.21 | 35.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Facility | 2020 | 11 | 11 | $371.25 | $215.16 | 58.0% |
About Amy Pontius, NP-C
Amy Pontius, NP-C is a Registered Nurse healthcare provider based in Gulfport, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1083159099.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Pontius, NP-C has received a total of $2,507 in payments from pharmaceutical and medical device companies, with $30.46 received in 2024. These payments were reported across 156 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,507).
As a Medicare-enrolled provider, Pontius has provided services to 963 Medicare beneficiaries, totaling 1,162 services with total Medicare billing of $57,350. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Gulfport, MS
- Active Since 12/29/2016
- Last Updated 05/13/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083159099
Products in Payments
- TRELEGY ELLIPTA (Drug) $598.52
- UBRELVY (Drug) $313.93
- Ozempic (Drug) $274.98
- FARXIGA (Drug) $210.47
- VRAYLAR (Drug) $125.89
- Tymlos (Biological) $114.78
- Wegovy (Drug) $90.87
- MYRBETRIQ (Drug) $68.30
- NURTEC ODT (Drug) $62.44
- Monarch Platform (Device) $60.51
- Rybelsus (Drug) $56.60
- Saxenda (Drug) $46.72
- QULIPTA (Drug) $44.32
- PIFELTRO (Drug) $36.49
- INJECTAFER (Drug) $33.34
- TRULICITY (Drug) $31.11
- Xofluza (Drug) $23.61
- RYBELSUS (Drug) $19.02
- Vascepa (Drug) $16.63
- SPRAVATO (Drug) $15.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Gulfport
Madelena Campbell, Rn, Cpnp-Bc, Cpn, RN, CPNP-BC, CPN
Registered Nurse — Payments: $5,015
Registered Nurse $5,015
Michelle Stewart
Registered Nurse — Payments: $4,223
Registered Nurse $4,223
Mrs. Addie Holcomb, Np, NP
Registered Nurse — Payments: $4,129
Registered Nurse $4,129
Mr. Ralph Burroughs, N.p, N.P
Registered Nurse — Payments: $2,930
Registered Nurse $2,930
Mrs. Amanda Miller, Fnp, FNP
Registered Nurse — Payments: $1,670
Registered Nurse $1,670
Miss. Cathy Kim, Np, NP
Registered Nurse — Payments: $300.27
Registered Nurse $300.27